Association between serum amyloid A and obesity: a meta-analysis and systematic review (Q37689003)

22 August 2017

0 references

1 reference

title

Association between serum amyloid A and obesity: a meta-analysis and systematic review (English)

1 reference

22 August 2017

0 references

0 references

1 reference

Yulan Zhao

1

1 reference

22 August 2017

Xuelian He

2

1 reference

22 August 2017

Xuegui Shi

3

1 reference

22 August 2017

Chengjin Huang

4

1 reference

22 August 2017

Jie Liu

5

1 reference

22 August 2017

Shuli Zhou

6

1 reference

22 August 2017

Chew-Kiat Heng

7

1 reference

22 August 2017

language of work or name

1 reference

7 February 2010

1 reference

22 August 2017

Inflammation Research

1 reference

22 August 2017

59

1 reference

22 August 2017

5

1 reference

22 August 2017

323-334

1 reference

https://scigraph.springernature.com/pub.10.1007/s00011-010-0163-y

22 August 2017

0 references

cites work

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Novel inflammatory markers of coronary risk: theory versus practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Covered stent septal ablation for hypertrophic obstruction cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Acute-phase serum amyloid A as a marker of insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Serum amyloid A attenuates cellular insulin sensitivity by increasing JNK activity in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0163-Y

Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.

21 January 2018

1 reference

12 December 2020

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

1 reference

12 December 2020

Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population

1 reference

12 December 2020

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

12 December 2020

Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss.

1 reference

12 December 2020

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

12 December 2020

Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study

1 reference

12 December 2020

Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function

1 reference

12 December 2020

Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice

1 reference

12 December 2020

Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics

1 reference

12 December 2020

Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction

1 reference

12 December 2020

Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals

1 reference

12 December 2020

Raised interleukin-6 levels in obese patients.

1 reference

12 December 2020

Association Between Low-Grade Systemic Inflammation and Type 2 Diabetes Mellitus Among Men and Women from the ATTICA Study

1 reference

12 December 2020

Inflammation, stress, and diabetes

1 reference

12 December 2020

Control of lipolysis and its relevance to development of obesity in man.

1 reference

12 December 2020

Serum amyloid A3 does not contribute to circulating SAA levels

1 reference

12 December 2020

Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice

1 reference

12 December 2020

Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.

1 reference

12 December 2020

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

1 reference

12 December 2020

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

1 reference

12 December 2020

Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.

1 reference

12 December 2020

Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.

1 reference

12 December 2020

Inflammation and metabolic disorders

1 reference

12 December 2020

Hyperglycemia-induced production of acute phase reactants in adipose tissue

1 reference

12 December 2020

Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study

1 reference

12 December 2020

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

12 December 2020

1 reference

12 December 2020

Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population

1 reference

12 December 2020

Adipokines as emerging mediators of immune response and inflammation.

1 reference

12 December 2020

Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects

1 reference

12 December 2020

A yearlong exercise intervention decreases CRP among obese postmenopausal women

1 reference

12 December 2020

Serum amyloid A protein regulates the expression of porcine genes related to lipid metabolism

1 reference

12 December 2020

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin

1 reference

12 December 2020

Sex differences in the relation of body composition to markers of inflammation

1 reference

12 December 2020

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

1 reference

12 December 2020

Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease

1 reference

12 December 2020

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

1 reference

12 December 2020

Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.

1 reference

12 December 2020

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

1 reference

12 December 2020

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

12 December 2020

Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree

1 reference

12 December 2020

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study

1 reference

12 December 2020

Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project

1 reference

12 December 2020

Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance.

1 reference

12 December 2020

Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study.

1 reference

12 December 2020

Serum amyloid A protein and carotid intima-media thickness in healthy young subjects

1 reference

12 December 2020

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes

1 reference

12 December 2020

Risk factors for coronary heart disease and acute-phase proteins. A population-based study

1 reference

12 December 2020

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications

1 reference

12 December 2020

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

1 reference

12 December 2020

Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition

1 reference

12 December 2020

Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study

1 reference

12 December 2020

Elevated C-reactive protein levels in overweight and obese adults

1 reference

12 December 2020

Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease

1 reference

12 December 2020

The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study

1 reference

12 December 2020

Established and emerging plasma biomarkers in the prediction of first atherothrombotic events

1 reference

12 December 2020

Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.

1 reference

12 December 2020

Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?

1 reference

12 December 2020

CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects

1 reference

12 December 2020

Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice

1 reference

12 December 2020

Both cyclooxygenase- and cytokine-mediated inflammation are associated with carotid intima-media thickness

1 reference

12 December 2020

Serum Amyloid A Concentration is Increased in Obese Children and Adolescents

1 reference

12 December 2020

Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation

1 reference

12 December 2020

Estimating the mean and variance from the median, range, and the size of a sample

1 reference

12 December 2020

Adipose tissue, inflammation, and cardiovascular disease

1 reference

12 December 2020

Inflammatory markers and in-hospital mortality in acute ischaemic stroke.

1 reference

12 December 2020

Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects

1 reference

12 December 2020

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

12 December 2020

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

1 reference

12 December 2020

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

1 reference

12 December 2020

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.

1 reference

12 December 2020

Evidence for a potent antiinflammatory effect of rosiglitazone

1 reference

12 December 2020

Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass.

1 reference

12 December 2020

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

1 reference

12 December 2020

Acute-phase proteins and other systemic responses to inflammation

1 reference

12 December 2020

Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study

1 reference

12 December 2020

Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status

1 reference

12 December 2020

Serum amyloid A and obstructive sleep apnea syndrome before and after surgically-induced weight loss in morbidly obese subjects

1 reference

12 December 2020

Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers

1 reference

12 December 2020

10.1007/S00011-010-0163-Y

Identifiers

DOI

1 reference

release_l4rrdosfgrcdzhcpzyook7juey

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l4rrdosfgrcdzhcpzyook7juey

24 November 2022

mapped directly with Wikidata item

1 reference